These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Biphasic emergence of active tuberculosis in rheumatoid arthritis patients receiving TNFα inhibitors: the utility of IFNγ assay. Chen DY; Shen GH; Chen YM; Chen HH; Hsieh CW; Lan JL Ann Rheum Dis; 2012 Feb; 71(2):231-7. PubMed ID: 22021896 [TBL] [Abstract][Full Text] [Related]
26. Screening for latent tuberculosis in anti-TNF-α candidate patients in a high tuberculosis incidence setting. Saidenberg-Kermanac'h N; Semerano L; Naccache JM; Brauner M; Falgarone G; Dumont-Fischer D; Guillot X; Valeyre D; Boissier MC Int J Tuberc Lung Dis; 2012 Oct; 16(10):1307-14. PubMed ID: 22863801 [TBL] [Abstract][Full Text] [Related]
27. Prevention of tuberculosis in patients taking tumor necrosis factor-alpha blockers. Bellofiore B; Matarese A; Balato N; Gaudiello F; Scarpa R; Atteno M; Bocchino M; Sanduzzi A J Rheumatol Suppl; 2009 Aug; 83():76-7. PubMed ID: 19661550 [TBL] [Abstract][Full Text] [Related]
28. The effects of rituximab therapy on released interferon-γ levels in the QuantiFERON assay among RA patients with different status of Mycobacterium tuberculosis infection. Chen YM; Chen HH; Lai KL; Hung WT; Lan JL; Chen DY Rheumatology (Oxford); 2013 Apr; 52(4):697-704. PubMed ID: 23264552 [TBL] [Abstract][Full Text] [Related]
29. Comparison of QuantiFERON-TB Gold test and tuberculin skin test for the identification of latent Mycobacterium tuberculosis infection in lupus patients. Yilmaz N; Zehra Aydin S; Inanc N; Karakurt S; Direskeneli H; Yavuz S Lupus; 2012 Apr; 21(5):491-5. PubMed ID: 22140142 [TBL] [Abstract][Full Text] [Related]
30. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population. Ponce de Leon D; Acevedo-Vasquez E; Alvizuri S; Gutierrez C; Cucho M; Alfaro J; Perich R; Sanchez-Torres A; Pastor C; Sanchez-Schwartz C; Medina M; Gamboa R; Ugarte M J Rheumatol; 2008 May; 35(5):776-81. PubMed ID: 18398944 [TBL] [Abstract][Full Text] [Related]
31. Tuberculosis screening in Portuguese healthcare workers using the tuberculin skin test and the interferon-gamma release assay. Torres Costa J; Sá R; Cardoso MJ; Silva R; Ferreira J; Ribeiro C; Miranda M; Plácido JL; Nienhaus A Eur Respir J; 2009 Dec; 34(6):1423-8. PubMed ID: 19948911 [TBL] [Abstract][Full Text] [Related]
33. Interferon-inducible protein-10 as a marker to detect latent and active tuberculosis in rheumatoid arthritis. Chen DY; Shen GH; Chen YM; Chen HH; Lin CC; Hsieh CW; Lan JL Int J Tuberc Lung Dis; 2011 Feb; 15(2):192-200. PubMed ID: 21219680 [TBL] [Abstract][Full Text] [Related]
34. Patients with psoriasis are more likely to be treated for latent tuberculosis infection prior to biologics than patients with inflammatory bowel disease. Bassukas ID; Kosmidou M; Gaitanis G; Tsiouri G; Tsianos E Acta Derm Venereol; 2011 Jun; 91(4):444-6. PubMed ID: 21547342 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of a new interferon-gamma release assay and comparison to tuberculin skin test during a tuberculosis outbreak. Song Q; Guo H; Zhong H; Liu Z; Chen X; Wang C; Touzjian N; Lv Y; Lu X; Wang Q Int J Infect Dis; 2012 Jul; 16(7):e522-6. PubMed ID: 22542006 [TBL] [Abstract][Full Text] [Related]
36. T cells co-producing Mycobacterium tuberculosis-specific type 1 cytokines for the diagnosis of latent tuberculosis. Nemeth J; Winkler HM; Karlhofer F; Selenko-Gebauer N; Graninger W; Winkler S Eur Cytokine Netw; 2010 Mar; 21(1):34-9. PubMed ID: 20146988 [TBL] [Abstract][Full Text] [Related]